Novelty Nobility
Operator of a biotech company intended to develop antibodies and antibody-drug conjugates to overcome drug resistance. The company focuses on researching novel factors for angiogenesis to develop ther...
Valuation
$10.8M
Market implied
Share Price
N/A
Total Raised
$60.8M
Last Round
N/A